Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial-Reference-Cited by-同舟云学术

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

Published:2024-01 Issue:1 Volume:23 Page:46-59
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Sharma Mukul,Molina Carlos A,Toyoda Kazunori,Bereczki Daniel,Bangdiwala Shrikant I,Kasner Scott E,Lutsep Helmi L,Tsivgoulis Georgios,Ntaios George,Czlonkowska Anna,Shuaib Ashfaq,Amarenco Pierre,Endres Matthias,Yoon Byung-Woo,Tanne David,Toni Danilo,Yperzeele Laetitia,von Weitzel-Mudersbach Paul,Sampaio Silva Gisele,Avezum Alvaro,Dawson Jesse,Strbian Daniel,Tatlisumak Turgut,Eckstein Jens,Ameriso Sebastián F,Weber Joerg R,Sandset Else Charlotte,Goar Pogosova Nana,Lavados Pablo M,Arauz Antonio,Gailani David,Diener Hans-Christoph,Bernstein Richard A,Cordonnier Charlotte,Kahl Anja,Abelian Grigor,Donovan Mark,Pachai Chahin,Li Danshi,Hankey Graeme J

Funder

Bristol-Myers Squibb Company

Janssen Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference38 articles.

1. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack;Wang;N Engl J Med,2013

2. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA;Johnston;N Engl J Med,2018

3. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA;Johnston;N Engl J Med,2020

4. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA;Wang;N Engl J Med,2021

5. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association;Kleindorfer;Stroke,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design;American Heart Journal;2024-11

2. Regulation of Platelet Activation and Coagulation;Interventional Cardiology Clinics;2024-10

3. Laboratory Evaluation of Interferences Associated with Factor XIa Inhibitors Asundexian and Milvexian in Routine Coagulation Assays;Diagnostics;2024-09-09

4. Milvexian, a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation;Expert Opinion on Drug Metabolism & Toxicology;2024-09-02

5. Factor XI inhibitors – Rising stars in anti-thrombotic therapy?;Journal of the Neurological Sciences;2024-09